In a new study, researchers evaluated the persistence of rAAV-mediated expression the gene encoding M-type ±-1 antitrypsin in patients that were AAT deficient
Are you trying to limit your intake of genetically modified foods? We’ve got the skinny on 15 products you’ll want to look out for… and some may surprise you. We probably don’t have to school you on GM foods, it’s history and the recent debates ...
To avoid getting squeezed by the Affordable Care Act, the Children's Hospital of Philadelphia is marketing itself globally and has begun doubling as a venture capital firm.
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BlueBird+%28BLUE%29+Enrolls+First+Patient+in+12+HGB-205+Study/8936324.html for the full story.
by Lucas M. Sjeklocha, Phillip Y.-P. Wong, John D. Belcher, Gregory M. Vercellotti, Clifford J. Steer The ultimate goal of gene therapy for sickle cell anemia (SCA) is an improved phenotype for the patient.
Dr. Timothy Stout, a leading researcher in gene therapy and eye diseases and a technology transfer specialist, is leaving Oregon Health & Science University to become chair of ophthalmology at Baylor College of Medicine in Houston.
SILVER SPRING, Md., Dec. 6, 2013 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that its wholly-owned subsidiary, ...
A fusion protein engineered by researchers at KU Leuven combining proteins active in HIV and Moloney murine leukaemia virus replication may lead to safer, more effective retroviral gene therapy.
Editas Medicine said Monday that it has closed $43 million in Series A financing. Flagship Ventures, Polaris Partners and Third Rock Ventures led the round with participation from Partners Innovation Fund.
The UK's first strategy to help build understanding of rare diseases and boost research to find effective treatments and therapies was launched by Health Minister Lord Howe today (November 22nd).The UK Rare Diseases Strategy aims to ensure that none ...